The 2022 updated Barcelona Clinic Liver Cancer strategy for prognosis prediction and treatment recommendation for HCC suggested evaluating prognosis according to the tumor burden and cancer-related symptoms, and defined by the AFP, albumin-bilirubin score, Child-Pugh, and MELD scores [47]. This evidence concerns the gene AFP and neoplasm.